Related content

NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

By Akcakanat Argun   Kanda Tatsuo   Koyama Yu   Watanabe Michitoshi   Kimura Eiji   Yoshida Yutaka   Komukai Shintarou   Nakagawa Satoru   Odani Shoji   Fujii Hiroshi   Hatakeyama Katsuyoshi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients

By Akiyama Yasuto   Komiyama Masaru   Miyata Haruo   Yagoto Mika   Ashizawa Tadashi   Iizuka Akira   Oshita Chie   Kume Akiko   Nogami Masahiro   Ito Ichiro   Watanabe Reiko   Sugino Takashi   Mitsuya Koichi   Hayashi Nakamasa   Nakasu Yoko   Yamaguchi Ken  

Oncology Reports, Vol. 31, Iss. 4, 2014-04 ,pp. : 1683-1690

Spandidos Publications

Access to resources Recommend Favorite

Recognition of naturally processed and ovarian cancer reactive CD8⁺ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1

By Matsuzaki Junko   Qian Feng   Luescher Immanuel   Lele Shashikant   Ritter Gerd   Shrikant Protul   Gnjatic Sacha   Old Lloyd   Odunsi Kunle  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1185-1195

Springer Publishing Company

Access to resources Recommend Favorite

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

By Wobser Marion   Keikavoussi Petra   Kunzmann Volker   Weininger Markus   Andersen Mads   Becker Juergen  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1294-1298

Springer Publishing Company

Access to resources Recommend Favorite

Vasoactive intestinal peptide induces CD14+HLA-DR/low myeloid-derived suppressor cells in gastric cancer

By                        

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 760-768

Spandidos Publications

Access to resources Recommend Favorite